Envision Pharma Limited

POWER SEARCH PRICING

SOLUTIONS

envision pharma limited Company Information

Company Number

04486293

Next Accounts

Sep 2025

Directors

Joshua Hollis Korth

Adam Deutsch

View All

Shareholders

envision pharma inc

Group Structure

View All

Industry

Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.

Registered Address

envision house 5 north street, horsham, west sussex, RH12 1XQ

Website

www.envisionpharmagroup.com

envision pharma limited Estimated Valuation

£4.3m

Pomanda estimates the enterprise value of ENVISION PHARMA LIMITED at £4.3m based on a Turnover of £7.3m and 0.59x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Envision Pharma Limited is a live company located in west sussex, RH12 1XQ with a Companies House number of 04486293. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in July 2002, it's largest shareholder is envision pharma inc with a 100% stake. Envision Pharma Limited is a mature, mid sized company, Pomanda has estimated its turnover at £7.3m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Envision Pharma Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating2out of 5

4 Strong

0 Regular

7 Weak

Size

annual sales of £7.3m, make it larger than the average company (£2.9m)

Growth

3 year (CAGR) sales growth of -10%, show it is growing at a slower rate (7.2%)

EXPORT

Envision Pharma Limited's latest turnover from December 2023 is £7.3 million and the company has net assets of -£34.8 million. According to their latest financial statements, Envision Pharma Limited has 404 employees and maintains cash reserves of £1.9 million as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Turnover	7,344,406	4,806,436	7,062,545	10,133,683	10,479,187	7,864,448	7,993,813	8,995,148	7,663,393	5,932,573	3,705,355	2,499,455	2,069,516	1,403,258	2,287,533
Other Income Or Grants
Cost Of Sales	5,177,149	3,998,281	5,778,623	6,448,151	6,312,376	4,956,328	5,225,226	4,419,456	4,429,480	3,876,949	3,779,822	1,532,807	1,024,230	867,568	1,053,414
Gross Profit	2,167,257	808,155	1,283,922	3,685,533	4,166,810	2,908,120	2,768,586	4,575,693	3,233,913	2,055,625	-74,467	966,648	1,045,286	535,691	1,234,119
Admin Expenses	6,163,252	9,901,870	11,352,561	12,844,151	6,351,495	6,863,764	3,937,053	5,219,816	2,677,258	1,892,627	1,470,642	1,030,497	605,326	642,738	544,897
Operating Profit	-3,995,995	-9,093,715	-10,068,639	-9,158,618	-2,184,685	-3,955,644	-1,168,467	-644,123	556,655	162,998	-1,545,109	-63,849	439,960	-107,047	689,222
Interest Payable	9,562				15						440				8,463
Interest Receivable	4,033	5,409	2,132	13,223	102,661	72,269	38,613	208	3,748	130		2,154		385	89
Pre-Tax Profit	-4,001,524	-9,088,305	-10,066,507	-9,145,395	-2,082,039	-3,883,374	-1,129,853	-643,914	560,404	163,129	-1,545,549	-61,694	439,960	-106,660	681,659
Tax	1,276,509	-99,575	34,332	-26,834	-143,722	-80,262	109,771	-95,716	-238,657	-141,634	121,685	30,242	22,593	85,377	28,335
Profit After Tax	-2,725,015	-9,187,881	-10,032,175	-9,172,228	-2,225,761	-3,963,635	-1,020,082	-739,630	321,747	21,495	-1,423,863	-31,452	462,553	-21,283	709,994
Dividends Paid											3,805,015
Retained Profit	-2,725,015	-9,187,881	-10,032,175	-9,172,228	-2,225,761	-3,963,635	-1,020,082	-739,630	321,747	21,495	-5,228,879	-31,452	462,553	-21,283	709,994
Employee Costs	7,514,639	10,005,399	5,616,539	15,009,860	6,984,743	7,625,076	7,845,572	6,684,790	6,646,447	6,452,167	6,851,993	5,113,142	4,519,431	3,657,747	3,689,560
Number Of Employees	404	116	101	92	49	102	97	93	140	132	94	87	77	67	71
EBITDA*	-3,363,939	-7,983,732	-9,513,900	-8,088,303	-1,529,140	-3,011,400	-792,959	-402,283	676,774	300,935	-1,514,530	54,035	508,639	-39,368	757,864

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Tangible Assets	781,245	1,227,865	1,696,390	1,648,618	1,574,951	1,524,953	755,433	611,101	491,070	370,190	375,385	324,310	446,928	396,531	400,001
Intangible Assets	31,014	61,808	142,767	503,564	955,145	1,475,509	1,930,255	1,810,732	1,113,898	577,631	117,656
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets	812,260	1,289,674	1,839,157	2,152,183	2,530,096	3,000,462	2,685,688	2,421,834	1,604,969	947,821	493,041	324,310	446,928	396,531	400,002
Stock & work in progress
Trade Debtors	2,348,900	2,255,412	811,266	640,212	674,207	545,198	836,115	472,085	318,790	351,702	639,596	566,650	40,539	153,914	281,881
Group Debtors	119,001,697	83,306,666	80,744,528	70,786,274	55,372,673	47,013,332	36,097,425	535,701	4,814,733	5,832,616	4,230,065	2,760,289	1,500,271	1,217,703	1,794,465
Misc Debtors	3,991,740	2,022,649	4,368,856	2,222,009	1,532,417	988,831	1,650,555	1,291,587	975,119	1,026,776	921,056	766,121	679,288	653,281	573,609
Cash	1,905,283	2,253,575	977,218	9,595,925	1,324,182	2,849,723	537,266	1,844,833	1,044,187	1,382,174	346,932	3,839,317	5,416,803	2,872,748	1,714,556
misc current assets
total current assets	127,247,621	89,838,303	86,901,869	83,244,421	58,903,480	51,397,085	39,121,362	4,144,207	7,152,830	8,593,268	6,137,650	7,932,378	7,636,902	4,897,648	4,364,512
total assets	128,059,881	91,127,977	88,741,027	85,396,603	61,433,575	54,397,547	41,807,050	6,566,041	8,757,798	9,541,089	6,630,690	8,256,689	8,083,830	5,294,179	4,764,514
Bank overdraft															4,767
Bank loan
Trade Creditors	2,627,845	1,045,699	1,411,860	515,852	726,219	274,037	497,985	325,030	580,565	170,705	388,923	46,326	92,660	8,101	45,600
Group/Directors Accounts	157,483,371	119,531,652	108,666,428	93,531,240	63,751,338	54,887,081	38,586,028	1,737,522	4,877,420	6,388,322	4,430,410	1,845,244	1,663,622	9,994	9,995
other short term finances						368,450		852,552
hp & lease commitments
other current liabilities	2,715,646	2,968,421	4,064,485	7,416,755	3,375,656	3,150,098	2,970,548	2,902,583	1,857,038	2,030,486	1,016,810	643,089	812,219	720,864	358,459
total current liabilities	162,826,862	123,545,772	114,142,773	101,463,848	67,853,214	58,679,667	42,054,562	5,817,688	7,315,024	8,589,514	5,836,143	2,534,660	2,568,502	738,959	418,821
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities			18,716
provisions		78,664	95,257	131,469	88,242		74,274	72,063	69,088						24,579
total long term liabilities		78,665	113,974	131,469	88,243		74,275	72,063	69,088						24,580
total liabilities	162,826,862	123,624,437	114,256,747	101,595,318	67,941,457	58,679,667	42,128,837	5,889,751	7,384,112	8,589,514	5,836,143	2,534,660	2,568,502	738,959	443,401
net assets	-34,766,981	-32,496,461	-25,515,720	-16,198,714	-6,507,881	-4,282,120	-321,788	676,290	1,373,686	951,576	794,547	5,722,029	5,515,329	4,555,220	4,321,113
total shareholders funds	-34,766,981	-32,496,461	-25,515,720	-16,198,714	-6,507,881	-4,282,120	-321,788	676,290	1,373,686	951,576	794,547	5,722,029	5,515,329	4,555,220	4,321,113

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Operating Activities
Operating Profit	-3,995,995	-9,093,715	-10,068,639	-9,158,618	-2,184,685	-3,955,644	-1,168,467	-644,123	556,655	162,998	-1,545,109	-63,849	439,960	-107,047	689,222
Depreciation	601,262	1,033,892	554,739	487,559	113,284	399,874	189,063	227,737	120,119	137,937	24,387	117,884	68,678	67,678	68,642
Amortisation	30,794	76,091		582,755	542,262	544,370	186,446	14,102			6,191
Tax	1,276,509	-99,575	34,332	-26,834	-143,722	-80,262	109,771	-95,716	-238,657	-141,634	121,685	30,242	22,593	85,377	28,335
Stock
Debtors	37,757,611	1,660,076	12,276,156	16,069,198	9,031,936	9,963,266	36,284,722	-3,809,269	-1,102,452	1,420,376	1,697,658	1,872,962	195,199	-625,057	2,649,956
Creditors	1,582,146	-366,161	896,007	-210,366	452,182	-223,949	172,956	-255,536	409,860	-218,218	342,597	-46,334	84,560	-37,500	45,600
Accruals and Deferred Income	-252,775	-1,096,064	-3,352,270	4,041,099	225,558	179,550	67,965	1,045,545	-173,448	1,013,676	373,721	-169,130	91,355	362,405	358,459
Deferred Taxes & Provisions	-78,664	-16,593	-36,212	43,227	88,242	-74,274	2,211	2,975	69,088					-24,579	24,579
Cash flow from operations	-38,594,334	-11,222,201	-24,248,199	-20,310,376	-9,938,815	-13,173,601	-36,724,777	4,104,253	1,846,069	-465,617	-2,374,186	-2,004,149	511,947	971,391	-1,435,119
Investing Activities
capital expenditure	-154,642	-560,500	-241,714	-692,401	-185,179	-1,259,018	-639,363	-1,058,704	-777,267	-592,717	-199,309	4,734	-119,075	-64,208	-468,643
Change in Investments
cash flow from investments	-154,642	-560,500	-241,714	-692,401	-185,179	-1,259,018	-639,363	-1,058,704	-777,267	-592,717	-199,309	4,734	-119,075	-64,208	-468,643
Financing Activities
Bank loans
Group/Directors Accounts	37,951,720	10,865,224	15,135,187	29,779,902	8,864,258	16,301,052	38,586,028	-4,877,420	-1,510,902	1,957,912	2,585,167	181,622	1,653,628	-1	9,995
Other Short Term Loans					-368,450	368,450	-852,552	852,552
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities		-18,716	18,716
share issue	454,494	2,207,141	715,169	-518,605		3,302	22,005	42,234	100,364	135,533	301,397	238,152	497,556	255,390	3,611,119
interest	-5,529	5,409	2,132	13,223	102,646	72,269	38,613	208	3,748	130	-440	2,154		385	-8,374
cash flow from financing	38,400,685	13,059,058	15,871,204	29,274,520	8,598,454	16,745,073	37,794,094	-3,982,426	-1,406,790	2,093,575	2,886,124	421,928	2,151,184	255,774	3,612,740
cash and cash equivalents
cash	-348,292	1,276,357	-8,618,707	8,271,743	-1,525,540	2,312,457	-1,307,568	800,646	-337,987	1,035,242	-3,492,386	-1,577,486	2,544,055	1,158,192	1,714,556
overdraft														-4,767	4,767
change in cash	-348,292	1,276,357	-8,618,707	8,271,743	-1,525,540	2,312,457	-1,307,568	800,646	-337,987	1,035,242	-3,492,386	-1,577,486	2,544,055	1,162,959	1,709,789

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for envision pharma limited. Get real-time insights into envision pharma limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for envision pharma limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other mid companies, companies in RH12 area or any other competitors across 12 key performance metrics.

ENVISION PHARMA LIMITED group structure

Envision Pharma Limited has 1 subsidiary company.

Ultimate parent company

ARDIAN FRANCE SA

#0105910

ENVISION PHARMA INC

#0080524

2 parents

ENVISION PHARMA LIMITED

04486293

1 subsidiary

ENVISION PHARMA FINCO LIMITED

10117627

ENVISION PHARMA LIMITED Shareholders

envision pharma inc

100%

Envision Pharma Limited currently has 3 directors. The longest serving directors include Mr Joshua Hollis Korth (Dec 2021) and Mr Adam Deutsch (Aug 2024).

officer	country	age	start	end	role
Mr Joshua Hollis Korth	England	50 years	Dec 2021	-	Director
Mr Adam Deutsch	United Kingdom	54 years	Aug 2024	-	Director
Mr Stanford Rudnick		41 years	Dec 2024	-	Director

P&L

December 2023

turnover

7.3m

+53%

operating profit

-4m

-56%

gross margin

29.6%

+75.5%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

-34.8m

+0.07%

total assets

128.1m

+0.41%

cash

1.9m

-0.15%

net assets

Total assets minus all liabilities

Similar Companies

modric developments limited

indigo planning limited

1.5

centre for effective dispute resolution limited

4.5

marketing in partnership limited

mac-interiors (london) limited

company number

04486293

Type

Private limited with Share Capital

industry

74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.

incorporation date

July 2002

ultimate parent company

ARDIAN FRANCE SA

previous names

N/A

address

envision house 5 north street, horsham, west sussex, RH12 1XQ

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 6 charges/mortgages relating to envision pharma limited. Currently there are 3 open charges and 3 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for ENVISION PHARMA LIMITED. This can take several minutes, an email will notify you when this has completed.

envision pharma limited Company Information

envision pharma limited Estimated Valuation

envision pharma limited Estimated Valuation

envision pharma limited Estimated Valuation

Envision Pharma Limited Overview

Envision Pharma Limited Health Check

ENVISION PHARMA LIMITED financials

envision pharma limited Credit Report and Business Information

Envision Pharma Limited Competitor Analysis

envision pharma limited Ownership

envision pharma limited directors

envision pharma limited company details

envision pharma limited Charges & Mortgages

envision pharma limited Capital Raised & Share Issues BETA

envision pharma limited Companies House Filings - See Documents